ResMed | RMD - 净收入

金融业

USD

USD 8.97B

现金及等价物

USD 1.47B

USD 612.93M

USD 4.32B

USD 1.4B

USD 843.17M

股息收益率

0.28

USD 454.34M

USD 559.78M

10.6K

EPS每股收益

USD 2.95

股本和储备

USD 6.59B

USD 861.22M

债务利息支出

USD 8.79M

USD 59K

USD 399.42M

USD 33.2B

USD 383.43M

USD 1.01B

USD 454.34M

普通股股本

USD 145.06M

18.29

USD 502.31M

USD 1.46B

销售和管理费用

USD 290.66M

USD 945.81M

贸易债权人

USD 308.92M

应收帐款人

USD 1.04B

	净收入	更改		日
Ansell	USD 88.8M		65.5M	2025-12
Artivion	USD 2.42M		4.07M	2025-12
AtriCure	USD 8.96M		8.85M	2026-06
Baxter International	USD 126M		141M	2026-06
Cochlear	AUD 161.5M		69.6M	2025-12
Cooper Companies	USD -77.9M		208.7M	2026-03
CSL	USD 401M		96.5M	2025-12
Dexcom	USD 249.1M		49.6M	2026-06
Edwards Lifesciences	USD 241.9M		138.8M	2026-06
Fisher Paykel Healthcare	NZD 255.5M		42.5M	2026-06
Globus Medical	USD 151.57M		27.27M	2026-06
Haemonetics	USD 33.01M		53.16M	2026-06
Idexx Laboratories	USD 338.41M		59.97M	2026-06
Inogen	USD -5.96M		373K	2024-09
Insulet	USD 95M		3.9M	2026-06
Integra LifeSciences	USD 4.48M		9.1M	2026-06
Intuitive Surgical	USD 818.1M		3.4M	2026-06
Medtronic	USD 1.24B		100M	2026-03
Philips	EUR 384M		233M	2026-06
Ramsay Health Care	AUD 152.7M		32.4M	2025-12
ResMed	USD 383.43M		15.3M	2026-06
Sigma Healthcare	AUD -6.72M		10.02M	2024-12
Sonic Healthcare	AUD 236.68M		82.29M	2024-12
Steris	USD 200.1M		20.2M	2026-06
Teleflex	USD 99.69M		107.85M	2026-06
Thermo Fisher Scientific	USD 1.74B		85M	2026-06